Access cutting-edge advanced cancer treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access advanced cancer specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced cancer treatment provided free
The purpose of this research is to study the safety and effects of single-dose psilocybin 25mg versus an active placebo (single dose niacin 100mg) in the treatment of anxiety, depression, and existential distress (i.e., loss of meaning and hope; fear of death) in advanced cancer (i.e., stage 3 or 4). Study medications will be administered in conjunction with brief psychotherapy that is designed to treat anxiety, depression and existential distress in advanced cancer.
Sponsor: NYU Langone Health
Check if you qualify for this advanced cancer clinical trial in New York, NY
If you're searching for advanced cancer treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.